Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0WJ8M
|
|||
| Drug Name |
U3-1402
|
|||
| Indication | Colorectal cancer [ICD-11: 2B91.Z] | Phase 2 | [1] | |
| Non-small-cell lung cancer [ICD-11: 2C25.Y; ICD-9: 162] | Phase 1 | [2] | ||
| Company |
Daiichi Sankyo Basking Ridge, NJ
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04479436) A Study to Evaluate U3-1402 in Subjects With Advanced or Metastatic Colorectal Cancer. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.